Top-News
Professionelle Dienstleistungen USA

Annovis Bio News

Aktie
WKN:  A2PNH2 ISIN:  US03615A1088 US-Symbol:  ANVS
6,49 €
-0,98 €
-13,12%
23.05.24 21:38:53
Handeln Depot/Watchlist
Aktienanzahl *
10,26 Mio.
Marktkapitalisierung *
72,51 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 08.11.2023

Annovis Bio News

04.05.22 - Newsfile
Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update
Berwyn, Pennsylvania--(Newsfile Corp. - May 4, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-​stage drug platform company addressing ...
28.04.22 - Newsfile
Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging
Collaboration to Develop Pharmacodynamic Biomarkers for Buntanetap
11.04.22 - Newsfile
Annovis Bio to Participate in World Parkinson's Day to Raise Awareness on the Debilitating Disease
Berwyn, Pennsylvania--(Newsfile Corp. - April 11, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-​stage drug platform company addressing ...
23.03.22 - Newsfile
Annovis Bio to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
Berwyn, Pennsylvania--(Newsfile Corp. - March 23, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-​stage drug platform company addressing ...
18.03.22 - Newsfile
Annovis Bio Presents at International Conference on Alzheimer's & Parkinson (AD/PD 2022)
Company Provides Update on Clinical Trial Design of Upcoming Phase 3 Clinical Trials in Parkinson's Disease on March 20, 2022
08.03.22 - Newsfile
Annovis Bio Announces Presentation at International Conference on Alzheimer's & Parkinson's Diseases 2022
Presentation will Showcase Trial Design in Upcoming Phase 3 Trial in Parkinson's Disease
03.03.22 - Newsfile
Annovis Bio to Present at the Cowen 42nd Annual Health Care Conference
Berwyn, Pennsylvania--(Newsfile Corp. - March 3, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-​stage drug platform company addressing ...
25.01.22 - Newsfile
Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson's Disease
FDA gives guidance for two Phase 3 clinical trials of Buntanetap in Parkinson's Disease
10.01.22 - Newsfile
Annovis Bio Enhances Leadership Team with Two Senior Appointments
Company Appoints Eve Damiano, MS, RAC, as Senior Vice President of Regulatory Operations
05.01.22 - Newsfile
Annovis Bio Announces Official Unique Name Buntanetap for Lead Candidate ANVS401
Berwyn, Pennsylvania--(Newsfile Corp. - January 5, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-​stage drug platform company addressing ...
03.01.22 - Newsfile
Annovis Bio to Participate in the Biotech Showcase and H.C. Wainwright Bioconnect Virtual Conferences
Company to Conduct Virtual One-​on-One Meetings During Biotech Showcase
20.12.21 - Newsfile
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
Berwyn, Pennsylvania--(Newsfile Corp. - December 20, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-​stage drug platform company ...
14.12.21 - Newsfile
Annovis Bio Announces Publication of ANVS401 Mechanism of Action in Peer-Reviewed Pharmaceutics
ANVS401 (Posiphen) Inhibits the Translation of mRNAs of Neurotoxic Proteins Responsible for the Progression of Neurodegenerative Diseases
12.07.21 - PR Newswire
Thinking about trading options or stock in Celldex Therapeutics, Tesla, Prothena Corp, Microsoft, or Annovis Bio?
Thinking about trading options or stock in Celldex Therapeutics, Tesla, Prothena Corp, Microsoft, or Annovis Bio? PR Newswire
23.06.21 - The Motley Fool
Diese 2 Biotech-Aktien sind dieses Jahr um 1.000 % gestiegen
Zuletzt gab es viele Berichte darüber, dass eine neue Behandlung der Alzheimer-​Krankheit (Alzheimer Disease, kurz AD) entwickelt wird. Dabei können die enormen Gewinne ...
19.06.21 - The Motley Fool
Statt Biogen-Aktie: Hier sind 2 bessere Alzheimer-Investments
Als die amerikanische Aufsichtsbehörde für Lebens- und Arzneimittel (FDA) den Wirkstoff Aducanumab von Biogen (WKN: 789617) zur Behandlung der Alzheimer-​Krankheit ...
21.05.21 - PR Newswire
Thinking about buying stock in Annovis Bio, Meten Edtechx Education, Onconova Therapeutics, General Electric, or AMC Entertainment?
Thinking about buying stock in Annovis Bio, Meten Edtechx Education, Onconova Therapeutics, General Electric, or AMC Entertainment? PR Newswire
25.08.20 - ACCESSWIRE
Annovis Bio to Present at The LD 500 Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / August 25, 2020 / Annovis Bio Inc. (NYSE American:ANVS), a clinical-​stage drug platform company addressing Alzheimer's disease (AD), ...

Newssuche

Videos

newspaper
23.05.24 -3,13%
Technical Trading: Sojabohnen im saisonalen Trend
Sojabohnen Long Typ: Turbo Open End WKN: VX41AH Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »